AGP Picks
View all

California Health Watch
Provided by AGP

California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 1, 2026

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 1, 2026

Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire
Tstrive Review: A New Balanced Look at the Men’s Vitality and Energy Supplement
May 1, 2026

Tstrive Review: A New Balanced Look at the Men’s Vitality and Energy Supplement

Indeterminate GlobeNewswire
Derma Essential Claims Evaluated: Investigating the Ingredients Inside DermaEssential Healthy Skin Support Formula
May 1, 2026

Derma Essential Claims Evaluated: Investigating the Ingredients Inside DermaEssential Healthy Skin Support Formula

Indeterminate GlobeNewswire
Gala GLP-1 Weight Loss Claims Evaluated: The Most Trusted GLP1 Tirzepetide Telehealth Prescription Treatment & Tracker Provider
May 1, 2026

Gala GLP-1 Weight Loss Claims Evaluated: The Most Trusted GLP1 Tirzepetide Telehealth Prescription Treatment & Tracker Provider

Indeterminate GlobeNewswire
Bestselling Author Debbi DiMaggio to be Featured Speaker at MFA Wellness Expo with Mindset In Motion™ Method on May 9
May 1, 2026

Bestselling Author Debbi DiMaggio to be Featured Speaker at MFA Wellness Expo with Mindset In Motion™ Method on May 9

Indeterminate EIN Presswire
What Happens After the Breakthrough: At KFSH, Innovation Is Measured by Repetition
May 1, 2026

What Happens After the Breakthrough: At KFSH, Innovation Is Measured by Repetition

Indeterminate GlobeNewswire
Human Garage launches Global 28-Day Reset on May 1 to help millions release stress and pain
May 1, 2026

Human Garage launches Global 28-Day Reset on May 1 to help millions release stress and pain

Indeterminate GlobeNewswire
Arvinas Announces FDA Approval of VEPPANU (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
May 1, 2026

Arvinas Announces FDA Approval of VEPPANU (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer

Indeterminate GlobeNewswire
Confluent Medical Technologies Names Tom Testa as Chief Operating Officer
May 1, 2026

Confluent Medical Technologies Names Tom Testa as Chief Operating Officer

Indeterminate GlobeNewswire
Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting
May 1, 2026

Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting

Indeterminate GlobeNewswire
Hyperion DeFi Schedules First Quarter Earnings Call for Thursday, May 14 at 8:00 a.m. ET
May 1, 2026

Hyperion DeFi Schedules First Quarter Earnings Call for Thursday, May 14 at 8:00 a.m. ET

Indeterminate GlobeNewswire
Reena Announces $1.9M Provincial Investment and Lead Donations for Thornhill Community Health Centre – A Reena Initiative
May 1, 2026

Reena Announces $1.9M Provincial Investment and Lead Donations for Thornhill Community Health Centre – A Reena Initiative

Indeterminate GlobeNewswire
Membrane and Filtration Market to Reach $591.2 Billion by 2030, Driven by Climate Change Infrastructure Investments
May 1, 2026

Membrane and Filtration Market to Reach $591.2 Billion by 2030, Driven by Climate Change Infrastructure Investments

Indeterminate GlobeNewswire
Youth reporting frequent thoughts of suicide reached record high in 2025, screening data show
May 1, 2026

Youth reporting frequent thoughts of suicide reached record high in 2025, screening data show

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

California Health Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.